This HTML5 document contains 180 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38209628
rdf:type
wikibase:Item
schema:description
artigo científico article scientifique wissenschaftlicher Artikel articolo scientifico artikel ilmiah наукова стаття, опублікована в травні 2014 vedecký článok বৈজ্ঞানিক নিবন্ধ scientific article published on 05 May 2014 مقالة علمية نشرت في 05 مايو 2014 videnskabelig artikel articol științific scienca artikolo scientific article published on 05 May 2014 bilimsel makale מאמר מדעי научни чланак artigo científico scientific article published on 05 May 2014 article científic vitskapeleg artikkel научная статья artigo científico vědecký článek vetenskaplig artikel artículo científico vitenskapelig artikkel artikull shkencor wetenschappelijk artikel artículu científicu espublizáu en 2014
p:P577
wds:Q38209628-7E4C0181-8D4C-4735-939D-D4623C76B514
wdt:P577
2014-05-05T00:00:00Z
p:P407
wds:Q38209628-95CE7566-834C-403E-90FB-DF5495D65067
wdt:P407
wd:Q1860
p:P2860
wds:Q38209628-11123C5B-06EE-4F01-B13B-909115AF144D wds:Q38209628-0921C9D5-F5F8-4B7B-B95E-4128255C4002 wds:Q38209628-A05732D6-282B-4578-A3C2-ADECC1F72D38 wds:Q38209628-A504126D-C21F-479D-ADAC-1017CD3CFFF5 wds:Q38209628-A7B6AE56-C46C-4FAC-A44E-9410E123CB1E wds:Q38209628-AA7BD156-BE52-450C-85B0-54CD5F8C8911 wds:Q38209628-9A4C29BE-E428-4B5F-A32D-C9D826693074 wds:Q38209628-C7AB490F-78EB-4BA8-A828-8DD80CB49832 wds:Q38209628-AE171915-1C2E-4C04-AB05-D70359AB6B13 wds:Q38209628-D664DB3F-995F-4F8E-BB3D-94145D65C33C wds:Q38209628-D920FAC8-117A-4921-B083-0208310BDCB7 wds:Q38209628-D9779A6E-486D-4292-801B-C5D4C237C410 wds:Q38209628-E43DC536-54EA-449A-821B-54686C0E45AC wds:Q38209628-CA0671D2-324D-4E4F-9319-00A65D373C4A wds:Q38209628-CAF27083-CD21-4E7C-8A48-FDE1A0AA708F wds:Q38209628-CDC2FC13-B702-4749-BF6C-B6C613131934 wds:Q38209628-F888F6CA-9F18-4256-B160-9317DD472373 wds:Q38209628-FA98FED9-76B4-4D42-87A6-A9B5F782AB3B wds:Q38209628-FC3075FE-37AF-4E08-A189-E2A8A8F5D109 wds:Q38209628-E77AE808-B560-4D2F-A5D4-439328ACA727 wds:Q38209628-252E9456-38D0-46BA-B094-25ADBB4A898E wds:Q38209628-2618FBD9-FA28-467E-92F8-5849C7042743 wds:Q38209628-2A2DBF2B-F307-4C21-A3AA-86257B38008E wds:Q38209628-1701ACC6-FB5C-490C-9265-6BDA0ED907E0 wds:Q38209628-1A5D5B9B-0D0A-4216-B909-97278049B3B1 wds:Q38209628-3CE39693-341C-4BAC-96AE-CD2CF939E8C1 wds:Q38209628-4524F570-A515-4F00-9DF0-45A766871F4B wds:Q38209628-2A7AC222-E061-4F2E-882E-4A27A69B6419 wds:Q38209628-2E69552F-77EB-40ED-B069-D0CFA221BB13 wds:Q38209628-31152651-9072-471A-8D97-FFA140D652BA wds:Q38209628-3690FCBE-069C-4EB2-A9C9-990A8FF4B83C wds:Q38209628-5D1DE1B7-B278-4B04-A418-B62B20AB15B1 wds:Q38209628-5DD73E08-4A39-4789-8471-1D80357E6749 wds:Q38209628-4B27D58F-776A-4C38-8ACF-AE99C0310975 wds:Q38209628-8D280242-4101-4C94-8089-10E0B607A112 wds:Q38209628-77294217-AD75-4F56-88E3-CAAE9C5D6DB1 wds:Q38209628-7752399C-C774-4864-9938-9901F994D532
wdt:P2860
wd:Q46865190 wd:Q27851549 wd:Q43289851 wd:Q44312099 wd:Q54566127 wd:Q37054957 wd:Q35695252 wd:Q57130157 wd:Q42599064 wd:Q27851403 wd:Q80112164 wd:Q35557031 wd:Q27851468 wd:Q30814798 wd:Q33393031 wd:Q46423034 wd:Q34613569 wd:Q40340899 wd:Q37163797 wd:Q24641848 wd:Q35584078 wd:Q51001768 wd:Q37660907 wd:Q35583927 wd:Q43937165 wd:Q46256397 wd:Q27851691 wd:Q47571979 wd:Q27851917 wd:Q84911213 wd:Q36376017 wd:Q84592604 wd:Q35809136 wd:Q35584284 wd:Q47951353 wd:Q35170258 wd:Q27824766
p:P2093
wds:Q38209628-05489042-7981-4E6E-A1AA-E0C33E530FF7 wds:Q38209628-0B72B903-89FD-4303-A568-66197FAE7811 wds:Q38209628-524C14B8-1F64-41C0-8FE8-29C30177644D wds:Q38209628-557EE9F8-1F52-4AB5-8C44-F3D53E56D298 wds:Q38209628-BA34C638-B356-4D87-8ED3-C7638C16BA22 wds:Q38209628-BBE6C418-C5CF-4751-A2A5-EF7CD854E93D
wdt:P2093
Jennifer Levinson Jane Perlmutter Nancy E Davidson Sarat Chandarlapaty Jeffrey J Kirshner Ian Krop
rdfs:label
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
skos:prefLabel
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
schema:name
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
p:P50
wds:Q38209628-E88549E9-D1AA-484D-B4C6-B5B7050978D7 wds:Q38209628-F805ADC5-3266-41C5-B6A4-FE3F2A75A75E wds:Q38209628-B8AA85FE-2065-409D-B27D-B3C409FFD927 wds:Q38209628-9471E5F6-038D-43E8-8371-869D3EA927E9 wds:Q38209628-7849E858-58B7-4EE8-A31A-C6EC376BAD14 wds:Q38209628-80B348AA-A4C9-4EEF-AB1C-4928387772F3 wds:Q38209628-4DBBCACB-33A2-4AC1-82DC-0FACBCDDEA19 wds:Q38209628-6E24B7F1-A787-425A-AC1F-0C94AFF6358C wds:Q38209628-750AD608-7EB5-4E02-931C-16C80C4F512B wds:Q38209628-39523381-18B4-4F95-BE64-D457FE5072E1 wds:Q38209628-29FBE320-5D7A-4F90-8213-9E3B647CB56F wds:Q38209628-0EEB99F3-26DE-4388-8F1A-1F2B00565638
wdt:P50
wd:Q42843998 wd:Q107718318 wd:Q125264095 wd:Q2843019 wd:Q125264975 wd:Q125263963 wd:Q125264325 wd:Q55640731 wd:Q18389345 wd:Q89531596 wd:Q16887072 wd:Q43937223
p:P1476
wds:Q38209628-23113CB3-A03A-49CD-BC57-B3318D078716
wdt:P1476
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
p:P304
wds:Q38209628-41931307-AAEC-4916-9BF7-9F7CC741882A
wdt:P304
2078-2099
p:P31
wds:Q38209628-12ADC9AC-86B0-407E-B795-2ECDD310A91F
wdt:P31
wd:Q13442814
p:P921
wds:Q38209628-7B3AE320-96F5-45F6-A6C7-859D7EB697DF wds:Q38209628-AEBA47B1-8EBA-4A1E-8EDD-FD2968E5B30B wds:Q38209628-C2C7FB5F-EFB8-4EFA-83D3-EBA7FA27C7B3
wdt:P921
wd:Q1929812 wd:Q12322152 wd:Q128581
p:P698
wds:Q38209628-F5C7F965-659E-46A3-A19E-BC541506EB79
wdtn:P698
n12:24799465
wdt:P698
24799465
p:P1433
wds:Q38209628-8BC7EFAC-CAD8-4123-95BD-7E6528B3FB2E
wdt:P1433
wd:Q400292
p:P433
wds:Q38209628-B03D7628-9836-43C9-A7EF-6C55FACCBD02
p:P478
wds:Q38209628-9F41897F-CB86-4CAA-8D91-AA6C996119AE
wdt:P433
19
wdt:P478
32
p:P356
wds:Q38209628-CF61189D-57C5-42A7-8551-1CD006C597DE
wdtn:P356
n10:JCO.2013.54.0948
wdt:P356
10.1200/JCO.2013.54.0948
p:P932
wds:Q38209628-12ED6B1D-06A8-443F-9DE4-8179E7CED0B8
wdt:P932
6076031